Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shunbin Ning

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Herpesviridae|March 25, 2011
Innate immune modulation in EBV infectionShunbin Ning
Viruses|March 6, 2021
TRIMming Type I Interferon-Mediated Innate Immune Response in Antiviral and Antitumor DefenseLing Wang, Shunbin Ning
AIMS Allergy and Immunology|December 5, 2017
"Toll-free" pathways for production of type I interferonsLing Wang, Shunbin Ning
Current Cancer Drug Targets|October 19, 2018
The Multifunctional Protein p62 and Its Mechanistic Roles in CancersShunbin Ning, Ling Wang
Journal of Virology|June 28, 2013
Interferon regulatory factor 4 is activated through c-Src-mediated tyrosine phosphorylation in virus-transformed cellsLing Wang, Shunbin Ning
Annals of Immunology & Immunotherapy|October 11, 2021
How Oncogenic Viruses Exploit p62-Mediated Selective Autophagy for Cancer DevelopmentShunbin Ning, Ling Wang
Cancers|November 13, 2021
New Look of EBV LMP1 Signaling LandscapeLing Wang, Shunbin Ning
Vaccines|March 28, 2024
Current Understanding of the Immune Response after COVID-19 VaccinationShunbin Ning, Davide Firinu
Journal of Virology|April 16, 2010
The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7Shunbin Ning, Joseph S Pagano
Journal of Virology|September 6, 2005
Interferon regulatory factor 5 represses expression of the Epstein-Barr virus oncoprotein LMP1: braking of the IRF7/LMP1 regulatory circuitShunbin Ning, Leslie E Huye, Joseph S Pagano
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Herpesviridae|March 25, 2011
Innate immune modulation in EBV infectionShunbin Ning
Viruses|March 6, 2021
TRIMming Type I Interferon-Mediated Innate Immune Response in Antiviral and Antitumor DefenseLing Wang, Shunbin Ning
AIMS Allergy and Immunology|December 5, 2017
"Toll-free" pathways for production of type I interferonsLing Wang, Shunbin Ning
Current Cancer Drug Targets|October 19, 2018
The Multifunctional Protein p62 and Its Mechanistic Roles in CancersShunbin Ning, Ling Wang
Journal of Virology|June 28, 2013
Interferon regulatory factor 4 is activated through c-Src-mediated tyrosine phosphorylation in virus-transformed cellsLing Wang, Shunbin Ning
Annals of Immunology & Immunotherapy|October 11, 2021
How Oncogenic Viruses Exploit p62-Mediated Selective Autophagy for Cancer DevelopmentShunbin Ning, Ling Wang
Cancers|November 13, 2021
New Look of EBV LMP1 Signaling LandscapeLing Wang, Shunbin Ning
Vaccines|March 28, 2024
Current Understanding of the Immune Response after COVID-19 VaccinationShunbin Ning, Davide Firinu
Journal of Virology|April 16, 2010
The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7Shunbin Ning, Joseph S Pagano
Journal of Virology|September 6, 2005
Interferon regulatory factor 5 represses expression of the Epstein-Barr virus oncoprotein LMP1: braking of the IRF7/LMP1 regulatory circuitShunbin Ning, Leslie E Huye, Joseph S Pagano
Pageof 7